Literature DB >> 2384919

Infection of nonlymphoid cells by human immunodeficiency virus type 1 or type 2.

K Ikeuchi1, S Kim, R A Byrn, S R Goldring, J E Groopman.   

Abstract

Human epithelial cells (L132) derived from embryonic lung and human lung fibroblasts (MRC5) were infected by human immunodeficiency virus type 1 (HIV-1) or type 2 (HIV-2). Surface CD4 protein was detected on these cells, and recombinant soluble CD4 (sCD4) blocked infection, indicating that HIV infection was mediated by the cell surface CD4 protein. In contrast, infection of human primary chondrocyte cells (C23), synovial cells (HSA), and foreskin fibroblasts (F13) was apparently independent of cell CD4-mediated mechanisms. Surface CD4 protein could not be detected on these cells, and sCD4 did not block the infection. F13 cells could be infected only by HIV-2, not by HIV-1, under our experimental conditions. In cells of mesenchymal orgin, viral production could be detected only after cocultivation with the human T-lymphoid H9 cells but not by conventional viral assays, including reverse transcriptase and p24 antigen assays in cell culture supernatant and immunofluorescence of host cells. Our DNA transfection studies indicated that this lack of detectable viral production was not due to the inefficient use of the HIV long terminal repeat or the Tat protein in these cells. These mesenchymal and epithelial cells were susceptible to HIV infection but differed in mechanism of virus entry compared with hematopoietic cells such as T lymphocytes. These observations may provide insights into clinical syndromes such as lung dysfunction in HIV-infected newborns and connective tissue disorders in HIV-infected adults.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384919      PMCID: PMC247887     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Isolation of human immunodeficiency virus from synovial fluid of a patient with reactive arthritis.

Authors:  R H Withrington; P Cornes; J R Harris; M H Seifert; E Berrie; D Taylor-Robinson; D J Jeffries
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

2.  Characterization of serum neutralization response to the human immunodeficiency virus (HIV).

Authors:  J E Groopman; P M Benz; R Ferriani; K Mayer; J D Allan; L A Weymouth
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

3.  Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes.

Authors:  M B Goldring; L J Sandell; M L Stephenson; S M Krane
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

4.  Human T lymphotropic virus type III infection of human alveolar macrophages.

Authors:  S Z Salahuddin; R M Rose; J E Groopman; P D Markham; R C Gallo
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

5.  Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients.

Authors:  C A Wiley; R D Schrier; J A Nelson; P W Lampert; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Human immunodeficiency virus can productively infect cultured human glial cells.

Authors:  C Cheng-Mayer; J T Rutka; M L Rosenblum; T McHugh; D P Stites; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.

Authors:  D H Smith; R A Byrn; S A Marsters; T Gregory; J E Groopman; D J Capon
Journal:  Science       Date:  1987-12-18       Impact factor: 47.728

8.  Modulation by recombinant interleukin 1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells.

Authors:  M B Goldring; S M Krane
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

9.  Infection of brain-derived cells with the human immunodeficiency virus.

Authors:  F Chiodi; S Fuerstenberg; M Gidlund; B Asjö; E M Fenyö
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

10.  Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus.

Authors:  A Adachi; S Koenig; H E Gendelman; D Daugherty; S Gattoni-Celli; A S Fauci; M A Martin
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

View more
  11 in total

Review 1.  Virus receptors: implications for pathogenesis and the design of antiviral agents.

Authors:  L C Norkin
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

2.  The majority of cells are superinfected in a cloned cell line that produces high levels of human immunodeficiency virus type 1 strain MN.

Authors:  D E Ott; S M Nigida; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

3.  Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA.

Authors:  K E Clemens; G Piras; M F Radonovich; K S Choi; J F Duvall; J DeJong; R Roeder; J N Brady
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  Enhanced in vitro human immunodeficiency virus type 1 replication in B cells expressing surface antibody to the TM Env protein.

Authors:  Y Tani; E Donoghue; S Sharpe; E Boone; H C Lane; S Zolla-Pazner; D I Cohen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 5.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

6.  A critical analysis of human immunodeficiency virus transmission using human cartilage allografts.

Authors:  J Bujía; P Pitzke; E Wilmes; C Hammer; L Gürtler
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 7.  HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

8.  Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.

Authors:  J A Hoxie; L F Brass; C H Pletcher; B S Haggarty; B H Hahn
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

9.  Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line.

Authors:  R Banerjee; J G Bekesi; A Tarcsafalvi; K Sperber; G Deak; H S Choi; F Paronetto; J F Holland; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission.

Authors:  X Tan; R Pearce-Pratt; D M Phillips
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.